Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases

What this Trial Is About

Researchers are collecting biological samples from patients with various liver diseases including Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Hepatitis C (HCV), Hepatitis B (HBV), and Human Immunodeficiency Virus (HIV). This biorepository aims to support research by providing high-quality specimens to help advance understanding and treatment of liver diseases. The project also promotes collaboration among clinicians and researchers and supports training for new investigators to improve patient health nationwide. The biorepository collects blood samples such as serum, plasma, buffy coat, and liver tissue from patients seen in clinics, including rarer liver diseases. Samples are stored and made available for future research to facilitate new discoveries in liver disease mechanisms and therapies. Both children and teenagers are considered special populations for this protocol, and negative control samples from individuals without liver disease are also included. Participants provide samples during clinic visits, and the main measure tracked is the number of samples collected over 52 weeks. This observational study involves no treatment but focuses on gathering clinically annotated human specimens. Participation may involve periodic blood draws and sharing medical information to contribute to liver disease research. The study is open to all genders aged 7 years and older and continues until December 2099.

Blood Collection Biorepository for Liver Disease Research